ARCHIVES

The 99th turned Out Well For Cancer Program, But Several Important Issues Await 100th Congress

This article is from The Cancer Letter archive.

Vol. 12 No. 42 | October 31, 1986

Download PDF Visit The Full Archive

Related Articles

Therapeutic Modalities Improve Patient Quality of Life In Trials

February 27, 2004

FDA Advisors: DepoCyt May Test Accelerated Approval Mechanism

November 27, 1998

FDA Updates Safety Information for 5-Alpha Reductase Inhibitors

June 17, 2011

FDA Approves Arranon For Leukemia And Lymphoma

December 30, 2005

In Brief: Larry Kun Was Named Clinical Director and Executive Vice President of St. Jude Children’s Research Hospital

November 1, 2013

NCI Considering Combining Support, Control Core Grants; Directors Reject Two Grants, One Review

June 2, 1978